Richard is the Founder and Director of RosettaPath, a science-based pathology consultancy providing research and toxicologic pathology expertise for biotech, pharmaceutical, contract research organisations, software vendors and academia. He has a keen interest in applying digital pathology, image analysis and AI to generate quantitative data to improve biological understanding, translational and predictive value of models, decision making and efficiency of medicine development Prior to RosettaPath, Richard led the Global Pathology team within Clinical Pharmacology & Safety Sciences at AstraZeneca which provides pathology expertise to assess nonclinical efficacy and safety of projects across a range of therapeutic modalities and diverse disease indications. Richard qualified in Veterinary medicine from the University of Cambridge, completed a DPhil at Oxford in experimental pathology and immunology, was Head of the UK Pathology department at GSK from 2014 to 2022 and is board certified in pathology (FRCPath, DipECVP) and toxicology (DABT).